pinocembrin has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valipour, M | 1 |
1 review(s) available for pinocembrin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Therapeutic prospects of naturally occurring p38 MAPK inhibitors tanshinone IIA and pinocembrin for the treatment of SARS-CoV-2-induced CNS complications.
Topics: COVID-19; Humans; p38 Mitogen-Activated Protein Kinases; SARS-CoV-2 | 2023 |